Clinical study of apatinib combined with EGFR‐TKI in the treatment of chronic progression after EGFR‐TKI treatment in non‐small cell lung cancer (ChiCTR1800019185)

This clinical trial (ChiCTR1800019185) is designed to be an open‐label, prospective, single‐center, single arm exploratory research study. The study will recruit non‐small cell lung cancer patients (NSCLC) with slow progression after first‐line treatment with EGFR‐TKI drugs. Slow progression will be...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorac Cancer
Autors principals: Li, Xin, Liu, Minghui, Zhang, Hongbing, Liu, Hongyu, Chen, Jun
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons Australia, Ltd 2020
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7049491/
https://ncbi.nlm.nih.gov/pubmed/31918452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13303
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars